Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Nanotech Market

Nanotech Stocks

Nanotech Market
Nanotech News
Nanotech Stocks

Nuvation Bio Inc.

NYSE:NUVB

Featured Articles and Interviews

More Featured Articles and Inverviews

Press Releases

Feb 29, 2024

Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Jan 08, 2024

Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors

Jan 08, 2024

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

More Press Releases

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.

Go Deeper

AI Powered

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch in 2025

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.